Paid Clinical Trials in Temple, TX
As of July 2026, 69 paid clinical trials are recruiting in Temple, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Temple offers studies at sites including Scott and White Memorial Hospital for conditions such as Heart Failure, Bladder Cancer, Breast Cancer, Chronic Kidney Disease(CKD). Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Temple
Trials by drug in Temple
Filter results
64 clinical trials
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
SELUTION 4 De Novo Small Vessel IDE Trial
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Top Research Study Locations in Temple
Researchers run research studies in Temple, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Scott and White Memorial Hospital | Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm | 20 |
| Baylor Scott & White Health | Acute Respiratory Distress Syndrome, Advanced/Metastatic Non-Small Cell Lung Cancer, Aging | 6 |
| Baylor Scott & White Medical Center - Temple | Cancer, Lower Extremity Arterial Disease, Multiple Myeloma | 6 |
| Baylor Scott & White Medical Center | Cancer Harboring BRAF Alterations, Cesarean Delivery, Colorectal Cancer | 3 |
| Baylor Scott and White Medical Center | Advanced Breast Cancer, Breast Cancer, HER2- Negative Breast Cancer | 3 |
| Baylor Scott & White | Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM) | 2 |
| Baylor Scott and White Health | Colorectal Neoplasms, Heart Failure | 2 |
| Baylor Scott and White Research | Chronic Myelogenous Leukemia - Chronic Phase, IC-MPGN | 2 |
| Central Texas Veterans Health Care System, Temple, TX | Post Traumatic Stress Disorder, Posttraumatic Stress Disorder | 2 |
| Baylor - Temple | Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III | 1 |
| Baylor Research Institute | Colon Cancer | 1 |
| Baylor Scott & White - Temple | Heart Failure | 1 |
| Baylor Scott & White Health Temple Market | Pediatric Disorder | 1 |
| Baylor Scott & White Healthcare | Alzheimer Disease, Dementia, Mild, Mild Cognitive Impairment | 1 |
| Baylor Scott & White Medical Centre - Temple | Obstructive Hypertrophic Cardiomyopathy | 1 |
| Baylor Scott & White Memorial Hospital | PFO - Patent Foramen Ovale, Stroke | 1 |
| Baylor Scott & White Research Institute | Heart Failure (HF) | 1 |
| Baylor Scott & White Vasicek Cancer Treatment Center | Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | 1 |
| Baylor Scott White Research Institute - Temple | Hepatitis | 1 |
| Baylor Scott and White - Temple | Coronary Artery Disease | 1 |
| Baylor Scott and White Biorepository | Advanced Solid Tumors Cancer, Bladder Cancer, Cancer | 1 |
| Baylor Scott and White Medical Center- Temple | Chronic Kidney Disease, Type 2 Diabetes | 1 |
| Baylor Scott and White Medical Center- Temple Clinic | Advanced Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer, Esophageal Adenocarcinoma | 1 |
| Baylor Scott and White Pain Clinic | Lumbar Spinal Stenosis | 1 |
| Baylor Scott and White Research Institute - Temple | Acute Severe Hypertension, Hypertension, Hypertensive Emergency | 1 |
Active & Upcoming Studies in Temple (2026)
Recruiting trials in Temple grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (28 active studies)
- A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) · Phase 2 · Regeneron Pharmaceuticals
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer · Phase 3 · Incyte Corporation
Cardiovascular (9 active studies)
- Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension · Phase 2 · Kardigan, Inc.
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (4 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) · Phase 4 · Baylor Research Institute
Neurology & pain (2 active studies)
Vaccines (1 active study)
Mental health & behavior (1 active study)
- Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center · Baylor Research Institute
Pediatric (1 active study)
- Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen? · Phase 4 · Baylor Research Institute
Common conditions studied in Temple
- Heart Failure (5 active studies)
- Cancer (3 active studies)
- Bladder Cancer (2 active studies)
- Breast Cancer (2 active studies)
- Chronic Kidney Disease(CKD) (2 active studies)
- Colorectal Cancer (2 active studies)
Leading research sponsors in Temple
- Baylor Research Institute
- Children's Oncology Group
- National Cancer Institute (NCI)
- AstraZeneca
- Hoffmann-La Roche
Frequently asked questions
How many paid clinical trials are currently recruiting in Temple?
There are approximately 69 recruiting clinical trials in Temple, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Temple pay participants?
Most recruiting trials in Temple compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Temple?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Temple?
The most common conditions under active study in Temple include Heart Failure (5), Cancer (3), Bladder Cancer (2), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Temple?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Temple on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Temple?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Temple?
Recruiting research sites in Temple include Scott and White Memorial Hospital, Baylor Scott & White Health, Baylor Scott & White Medical Center - Temple, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Temple right now?
The largest active categories in Temple are Cancer & tumors (28), Cardiovascular (9), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.